MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Lewy bodies"

  • 2022 International Congress

    Incidental Lewy Body disease and idiopathic Parkinson’s disease: from common pathogenic factors to the overlapping clinical features

    E. Sansa, T. Warner, E. Depablo Fernandez (London, United Kingdom)

    Objective: To compare established early symptoms and risk factors associated with Parkinson’s disease (PD) in a cohort of incidental Lewy Body disease (iLBD) and healthy…
  • 2022 International Congress

    Sex Modulates Cognitive Association of Lewy Body Pathology

    E. Bayram, K. Wang, A. Tsai, D. Coughlin, I. Litvan (La Jolla, USA)

    Objective: To assess whether the association between Lewy body (LB) pathology stages and cognition differs for women and men Background: Progression of LB pathology is…
  • 2022 International Congress

    Blaming neuromelanin for Parkinson’s disease: time-dependent tyrosinase overexpression drives endogenous synucleinopathy in non-human primates

    J. Lanciego, J. Chocarro, A. Fajardo-Serrano, A. Vazquez, AI. Rodriguez-Perez, J. Labandeira-Garcia, M. Vila, A. Rico (Pamplona, Spain)

    Objective: Development and characterization of a novel non-human primate model of Parkinson’s disease based on the AAV-mediated forced expression of human tyrosinase Background: Although neuromelanin…
  • 2022 International Congress

    Smoking and Substantia Nigra Neuron Density in the Presence and Absence of Lewy Pathology

    G. Ross, R. Abbott, H. Petrovitch, J. Duda, J. Uyehara-Lock, K. Masaki, C. Tanner (Honolulu, USA)

    Objective: Our objective is to examine the association of mid-life smoking with post mortem substantia nigra (SN) neuron density in the presence and absence of…
  • MDS Virtual Congress 2021

    Differential methylation signatures in Lewy body dementia

    P. Reho, TG. Beach, GE. Serrano, KL. Newell, HP. Easwaran, JC. Troncoso, O. Pletnikova, SW. Scholz (Bethesda, USA)

    Objective: This study aimed to compare the DNA methylome of Lewy body dementia (LBD) patients and healthy controls. Background: LBD is the second most common…
  • MDS Virtual Congress 2021

    Sex-Specific APOE ε4 Association with Cognition in Lewy Body Dementia

    E. Bayram, S. Scholz, I. Litvan (La Jolla, USA)

    Objective: To evaluate whether association between apolipoprotein E ε4 (APOE ε4) and cognition differ for men and women with pathologically-confirmed Lewy body dementia (LBD). Background:…
  • MDS Virtual Congress 2021

    Association between Alzheimer’s disease co-pathology and neuropsychiatric symptoms in Lewy body dementia

    J. Dipane, D. Coughlin, E. Bayram (La Jolla, USA)

    Objective: To identify the associations between Alzheimer Disease (AD) co-pathology and neuropsychiatric symptoms in Lewy body dementia (LBD). Background: Dementia with Lewy Bodies (DLB) and…
  • MDS Virtual Congress 2021

    Olfactory dysfunction in incidental Lewy body disease and Parkinson’s disease: An update

    S. Hasan, C. Adler, N. Zhang, G. Serrano, H. Shill, S. Mehta, T. Beach, E. Driver-Dunckley (Scottsdale, USA)

    Objective: Using a larger sample size compared to our previous study, we evaluated the relationship between olfactory dysfunction based on the University of Pennsylvania Smell…
  • MDS Virtual Congress 2020

    Tau Neuropathology Associates with In Vivo Patterns of Neurodegeneration in Lewy Body Disorders

    N. Spotorno, D. Coughlin, L. Shaw, A. Chen-Plotkin, D. Weintraub, E. Lee, J. Trojanowski, C. McMillan, D. Irwin, M. Grossman (Philadelphia, PA, USA)

    Objective: Investigate the impact of Alzheimer’s disease (AD) co-pathology on an in vivo structural measure of neurodegeneration in Lewy Body disorders (LBD: Parkinson’s Disease and…
  • MDS Virtual Congress 2020

    Sex Moderates the Effects of Neurofibrillary Tangles on Cognition for Diffuse Lewy Body Pathology

    E. Bayram, I. Litvan (La Jolla, CA, USA)

    Objective: To evaluate (1) the association between neurofibrillary tangle staging and cognition for participants with diffuse Lewy Body (LB) pathology, (2) whether this association differs…
  • « Previous Page
  • 1
  • …
  • 4
  • 5
  • 6
  • 7
  • 8
  • …
  • 11
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley